U.S. Physical Therapy, Inc. (NYSE:USPH) Receives $125.67 Consensus PT from Analysts

Shares of U.S. Physical Therapy, Inc. (NYSE:USPH) have received a consensus rating of “Buy” from the four research firms that are currently covering the firm, Marketbeat reports. Four investment analysts have rated the stock with a buy recommendation. The average 1-year target price among analysts that have issued a report on the stock in the last year is $125.67.

A number of equities analysts have commented on the stock. Barrington Research restated an “outperform” rating and issued a $122.00 price target on shares of U.S. Physical Therapy in a research report on Thursday, May 9th. StockNews.com raised shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Monday, March 18th. Finally, JPMorgan Chase & Co. upped their target price on shares of U.S. Physical Therapy from $99.00 to $117.00 and gave the company an “overweight” rating in a research note on Wednesday, March 13th.

Insiders Place Their Bets

In other news, CEO Christopher J. Reading sold 1,100 shares of the firm’s stock in a transaction that occurred on Tuesday, May 28th. The shares were sold at an average price of $102.13, for a total value of $112,343.00. Following the sale, the chief executive officer now directly owns 99,738 shares in the company, valued at approximately $10,186,241.94. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In related news, CEO Christopher J. Reading sold 2,900 shares of U.S. Physical Therapy stock in a transaction that occurred on Thursday, May 30th. The shares were sold at an average price of $100.26, for a total transaction of $290,754.00. Following the sale, the chief executive officer now directly owns 95,838 shares in the company, valued at approximately $9,608,717.88. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Christopher J. Reading sold 1,100 shares of the firm’s stock in a transaction that occurred on Tuesday, May 28th. The stock was sold at an average price of $102.13, for a total transaction of $112,343.00. Following the transaction, the chief executive officer now owns 99,738 shares of the company’s stock, valued at approximately $10,186,241.94. The disclosure for this sale can be found here. Insiders have sold 10,724 shares of company stock worth $1,114,385 over the last ninety days. Corporate insiders own 1.70% of the company’s stock.

Institutional Trading of U.S. Physical Therapy

Hedge funds have recently modified their holdings of the stock. Northwest Bank & Trust Co purchased a new position in U.S. Physical Therapy during the 4th quarter worth $37,000. SRS Capital Advisors Inc. raised its position in shares of U.S. Physical Therapy by 308.0% in the fourth quarter. SRS Capital Advisors Inc. now owns 408 shares of the company’s stock worth $38,000 after buying an additional 308 shares in the last quarter. Benjamin F. Edwards & Company Inc. boosted its position in shares of U.S. Physical Therapy by 268.5% during the 1st quarter. Benjamin F. Edwards & Company Inc. now owns 549 shares of the company’s stock valued at $61,000 after acquiring an additional 400 shares during the last quarter. Principal Securities Inc. purchased a new position in shares of U.S. Physical Therapy during the fourth quarter worth about $100,000. Finally, Advisors Asset Management Inc. grew its holdings in shares of U.S. Physical Therapy by 78.4% during the first quarter. Advisors Asset Management Inc. now owns 1,056 shares of the company’s stock worth $119,000 after purchasing an additional 464 shares in the last quarter.

U.S. Physical Therapy Trading Down 1.0 %

Shares of NYSE:USPH opened at $94.31 on Friday. The firm has a fifty day moving average of $100.59 and a two-hundred day moving average of $99.85. The firm has a market capitalization of $1.42 billion, a P/E ratio of 76.67, a price-to-earnings-growth ratio of 3.58 and a beta of 1.41. U.S. Physical Therapy has a 12-month low of $78.08 and a 12-month high of $124.11. The company has a quick ratio of 2.16, a current ratio of 2.16 and a debt-to-equity ratio of 0.28.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings results on Tuesday, May 7th. The company reported $0.51 earnings per share for the quarter, missing analysts’ consensus estimates of $0.58 by ($0.07). The business had revenue of $155.70 million for the quarter, compared to the consensus estimate of $153.30 million. U.S. Physical Therapy had a net margin of 4.72% and a return on equity of 8.03%. The firm’s revenue for the quarter was up 4.8% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.59 EPS. On average, equities analysts expect that U.S. Physical Therapy will post 2.84 EPS for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, June 14th. Investors of record on Thursday, May 23rd were given a dividend of $0.44 per share. This represents a $1.76 dividend on an annualized basis and a yield of 1.87%. The ex-dividend date of this dividend was Wednesday, May 22nd. U.S. Physical Therapy’s dividend payout ratio is 143.09%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.